FDA Inspection
Sperm Bank, IncSperm Bank, Inc – FDA Inspection, Jun 12, 2024
Record Details
This FDA Inspection record concerns Sperm Bank, Inc, with an inspection on June 12, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 097ab2fc-d0bb-47cc-ae3c-847c5c7c41f9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1241773
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.47(a)Design of procedures to ensure compliance
- 21 CFR 1271.85(a)Infection with communicable disease agents
- 21 CFR 1271.80(b)Specimen collections not timely
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sperm Bank, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 15, 2025 | Not classified | Los Angeles District Office | |
| February 28, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 12, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 12, 2009 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Sperm Bank, Inc
- FDA Inspection 1287950 - 2025-10-15
- FDA Inspection 1085581 - 2019-02-28
- FDA Inspection 1037747 - 2017-12-12
- FDA Inspection 587399 - 2009-06-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.